breast neoplasms
Showing NaN - NaN of 41
Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)
Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed
Active, not recruiting
- Breast Neoplasms
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
- +7 more
-
Birmingham, Alabama
- +26 more
Dec 21, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
DCIS, Breast Cancer, Breast Tumors Trial in Hong Kong, Sweden, United States (Delayed SLND, Late SLND)
Recruiting
- DCIS
- +3 more
- Delayed SLND
- Late SLND
-
Houston, Texas
- +8 more
Mar 14, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)
Recruiting
- Breast Cancer Stage IV
- +3 more
-
Houston, TexasBaylor College of Medicine
Jun 1, 2021
Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)
Terminated
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +2 more
-
Bakersfield, California
- +70 more
Jul 29, 2020
Breast Tumors Trial in Houston (Informed breast cancer surgical treatment)
Completed
- Breast Neoplasms
- Informed breast cancer surgical treatment
-
Houston, TexasBaylor College of Medicine
Feb 26, 2020
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)
Terminated
- Breast Neoplasms
- +2 more
-
Greenbrae, California
- +70 more
Oct 10, 2019
Breast Cancer, Breast Tumors Trial in Los Angeles, Houston (Self-Regulation Condition, Enhanced self-Regulation Condition)
Completed
- Breast Cancer
- Breast Neoplasms
- Self-Regulation Condition
- Enhanced self-Regulation Condition
-
Los Angeles, California
- +1 more
Sep 2, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Breast Tumors Trial in Worldwide (Carboplatin, Docetaxel, Pertuzumab)
Breast Tumors Trial in United States (Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2, Ixabepilone, 32 mg/m^2 + Capecitabine,
Terminated
- Breast Neoplasms
- Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2
- +2 more
-
Tuscaloosa, Alabama
- +59 more
Feb 9, 2016
Breast Tumors Trial in Worldwide (CP-751,871, exemestane, Fulvestrant)
Breast Tumors Trial in United States (exemestane (Aromasin), tamoxifen + exemestane)
Completed
- Breast Neoplasms
- exemestane (Aromasin)
- tamoxifen + exemestane
-
Bessemer, Alabama
- +178 more
Oct 6, 2015
Breast Tumors, Tumors, Hormone-dependent Trial in Worldwide (atamestane, toremifene, letrozole)
Completed
- Breast Neoplasms
- Neoplasms, Hormone-dependent
- atamestane
- +6 more
-
Lake Havasu City, Arizona
- +62 more
Jul 29, 2015